Barely Significant

Excerpts

514,629 sentences

highly significantP<0.0010.0× alphaqualifiedgold
Cells pre-treated with morin showed a highly significant (P<0.001) decline in the ROS generation by 2.33 fold in comparison to glucose stressed cells, whereas, 1.75 fold (P<0.001) and 1.6 fold (P<0.01) decrease in ROS generation was observed in co- treated and post- treated hepatocytes ( Fig. 1c ).
highly significantp < 0.0010.0× alphaqualifiedgold
Frequency dependence of resistance(fdr = R5-R20), which is the most specific indicator of peripheral resistance [ 33 , 34 ], increased significantly in MA subgroup (+72.1 %), whereas it decreased significantly in HS-subgroup (−50 %), and the difference among the changes was highly significant ( p < 0.001, Fig. 1a ).
highly significantp < 0.0010.0× alphaqualifiedgold
One-way ANOVA revealed highly significant treatment effects on circulating cTnT (F(3,24) = 32.166, p < 0.001), CK (F(3,24) = 23.908, p < 0.001), CK-MB levels (F(3,24) = 26.760, p < 0.001) and LDH (F(3,24) = 146.200, p < 0.001).
highly significantP <0.0010.0× alphaqualifiedgold
Both the results were statistically highly significant ( P <0.001) [Tables 2 – 7 ] Agni Bala Pariksha In Agnibala Pariksha , 80.76% of the improvement was recorded in the Ruchira-Aharkale , 63.49% in Abhyavarana Shakti and 54.95% improvement in Jarana Shakti after the treatment in group A, while 84.41% of the improvement was recorded in the Ruchira-Aharkale , 65% in Abhyavarana Shakti and 50.43% improvement in Jarana Shakti recorded in group B.
highly significantp<0.0010.0× alphaqualifiedgold
Leading to a correct classification of 83.8% of cases (95.1% of cases without and 53.3% of cases with UHR criteria), the model became highly significant (Omnibus test: χ 2 (3) = 38.883, p<0.001) and explained 39.2% of the variance ( Table 5 ).
highly significantP < .0010.0× alphaqualifiedgold
There was a highly significant correlation between the 2 methods when the assay was changed from RIA to ACS-180 in 1998 ( P < .001; r 2 = 0.94) and when it was changed from ACS-180 to DELFIA in 2003 ( P < .001; r 2 = 0.99). 100% agreement for screening passes and failures was obtained using the revised cut-off values.
highly significantP<0.0010.0× alphaqualifiedgold
Pooled analysis across all cancers demonstrated highly significant evidence of differences overall showing longer diagnostic intervals with increasing age (7.8 days; 6.4 to 9.1; P<0.001); for females (8.9 days; 5.5 to 12.2; P<0.001); and in non-NICE symptoms (27.7 days; 23.9 to 31.5; P<0.001).